Plné znění - 80/2017 Sb. m. s.

Sdělení o přijetí nového znění Přílohy I (Seznam zakázaných látek a metod dopingu pro rok 2017 - Mezinárodní standard) Mezinárodní úmluvy proti dopingu ve sportu

80/2017 Sb. m. s.

Sdělení

INFORMACE

80

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxx věcí,

kterým xx xxxx x xxxxxxxx sdělení Xxxxxxxxxxxx xxxxxxxxxxxx věcí x. 58/2007 Xx. x. x. x x. 46/2008 Sb. x. x.

 

Xxxxxxxxxxxx zahraničních věcí xxxxxxx, xx xxx 28. listopadu 2016 xxxx generální xxxxxxxxxx XXXXXX oznámeno xxxxxxxxx xxxxxx xxxxx Xxxxxxx X (Xxxxxx zakázaných xxxxx a xxxxx xxxxxxx xxx xxx 2017 - Xxxxxxxxxxx xxxxxxxx) Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾.

X xxxxx zněním Xxxxxxx X xxxxxxxx xxxxxxx Xxxxxxxxx Xxxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx x xxxxxxx změn Xxxxxxx I Českou xxxxxxxxxx.

Xxxx xxxxx Xxxxxxx X xxxxxxxxx v xxxxxxxx x souladu x článkem 34 odst. 3 Xxxxxx xxx 1. xxxxx 2017 x pro Xxxxxx xxxxxxxxx xxxxxxxxx v xxxxxxxx dne 30. xxxxx 2017.

Xxxx vstupu xxxxxx znění Přílohy X x xxxxxxxx xxxxxxxx xxxxxx xxxxx Xxxxxxx X xxxxxx xx 1. xxxxx 2016, xxxxxxxxx xxx č. 26/2017 Sb. m. s.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx do xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

XXXXXXX XXXXXXXXXXXXX KODEX

SEZNAM XXXXXXXXXX LÁTEK X XXXXX XXXXXXX PRO XXX 2017

XXXXXXXXXXX XXXXXXXX

Xxxxxxxxx xxxx Seznamu xxxx xxxxxxxxx XXXX x xxxx xxxxxxxxxx x xxxxxxxxxx a francouzštině.

V xxxxxxx xxxxxxxxxxx konfliktů xxxx xxxxxxxxx a xxxxxxxxxxxx verzí bude xxxxxxxxxxx anglická verze.

Tento Xxxxxx xxxx xxxxxx xx 1. ledna 2017 

XXXXXX XXXXXXXXXX XXXXX X XXXXX XXXXXXX XXX XXX 2017

SVĚTOVÝ XXXXXXXXXXXXX KODEX

Platný xx 1. ledna 2017

Podle xxxxxx 4.2.2 Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxx všechny Xxxxxxxx xxxxx budou xxxxxxxxxx za "Specifické xxxxx" kromě látek xx xxxxxx X1, X2, X4.4, X4.5 x X6(x) a Xxxxxxxxxx metod M1, X2 x X3.

XXXXX X METODY XXXXXXXX XXXXX (XXX SOUTĚŽI X XXXX SOUTĚŽ)

ZAKÁZANÉ LÁTKY

S0. XXXXXXXXXXX LÁTKY

Jakákoliv xxxxxxxxxxxxxx xxxxxx xxxxx, xxxxx xxxx xxxxxxxx v xxxxxxxxxxxxx xxxxxxx Seznamu x není xxxxxxxx xxxxxxxxx pro humánní xxxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxx (např. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx xxxxxx výzkumu xxxx xx xxxxxxxx xxxxxxxxxx, xxxxxxxxxx xxxxx, xxxxx schválené pouze xxx veterinární použití), xx xxxxxxxx stále.

S1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

(x) Xxxxxxxx* XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx);

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx);

xxxxxxxxx (estr-4-en-3ß, 17ß-xxxx);

xxxxxxxxxx;

xxxxxxx ([1,2]xxxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx);

xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);

xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17ß-xx);

xxxxxxxxxxx;

xxxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx);

xxxxxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx (17α-xxxxxx[1,2,5]xxxxxxxxxx[3',4':2,3]-5α-xxxxxxxxx-17ß-xx);

xxxxxxxxx;

4-xxxxxxxxxxxxxxxxxx (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx);

xxxxxxxxxx;

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx (17ß-hydroxy-17α-methylandrosta-1,4-dien-3-on);

metenolon;

methandriol;

metasteron (17ß-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx);

xxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx);

xxxxxx-1-xxxxxxxxxxx (17ß-hydroxy-17α-methyl-5α-androst-1-en-3-on);

methylnortestosteron (17ß-hydroxy-17α-methylestr-4-en-3-on);

methyItestosteron;

metribolon (xxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxxxxx;

xxxxxxxxxxxx;

xxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx);

xxxxxxxxx;

xxxxxxxxxx;

xxxxxxxxx;

1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx);

xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx);

xxxxxxxxx (17ß-hydroxyestr-4,9,11-trien-3-on);

a xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx** AAS, xxxxx jsou xxxxxx xxxxxxxx:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3ß,17ß-xxxx);

xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx);

xxxxxxxx;

xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx);

xxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxxxx-3xx); 

xxxxxxxxx (19-xxxxxxxxxxxxxx);

19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);

19-xxxxxxxxxxxxxxxx (estr-4-en-3,17-dion);

prasteron (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx);

xxxxxxxxxxx;

x xxxxxx xxxxxxxxxx x isomery, xxx xx x xxxxxxxx xxxxx na xx:

5α-xxxxxxxxx-3α,17α-xxxx;

5α-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxxxx-3ß,17α-xxxx;

5α-xxxxxxxxx-3ß,17ß-xxxx;

5ß-xxxxxxxxx-3α,17ß-xxxx;

5α-xxxxxxx-2-xx-17-xx;

xxxxxxx-4-xx-3α,17α-xxxx;

xxxxxxx-4-xx-3α,17ß-xxxx;

xxxxxxx-4-xx-3ß,17α-xxxx;

xxxxxxx-5-xx-3α,17α-xxxx;

xxxxxxx-5-xx-3α,17ß-xxxx;

xxxxxxx-5-xx-3ß,17α-xxxx;

4-xxxxxxxxxxxxx (androst-4-en-3ß,17ß-diol);

5-androstendion (androst-5-en-3,17-dion);

androsteron;

epi-dihydrotestosteron;

epitestosteron;

etiocholanolon;

3ß-hydroxy-5α-androstan-17-on;

7α-hydroxy-DHEA;

7ß-hydroxy-DHEA;

7-keto-DHEA;

19-norandrosteron;

19-noretiocholanolon.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx; selektivní modulátory xxxxxxxxxxxxx receptorů (XXXX, xxxx. xxxxxxx a xxxxxxx); xxxxxxx; xxxxxxx x zilpaterol, xxx xx x xxxxxxxx xxxxx xx xx.

Xxx xxxxx skupiny xxxx xxxxx: * "exogenní" xx xxxxxxxx k xxxxx, xxxxxx xxxx normálně xxxxxxxxx xxxxxxxxxxx. ** "endogenní " xx vztahuje x xxxxx, xxxxxx xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx.

X2. XXXXXXXXX HORMONY, XXXXXXX XXXXXXX, XXXXXXXX XXXXX X MIMETIKA

Následující xxxxx x xxxxx xxxxx s xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx biologickými xxxxxx xxxx xxxxxxxx:

1. Xxxxxxxx xxxxxxxxxxxxxxxxx receptoru:

1.1 Látky xxxxxxxxxxx xxxxxxxxxxx (XXX) xxxxxx xxxx.

xxxxxxxxxxxx (xXXX);

xxxxxxxxxxxxx (XXX);

XXX-Xx;

XXX-xxxxxxxxxxx xxxxxxx (EMP), xxxx. XXXX 530 x xxxxxxxxxxx;

xxxxxxxxxx XXXX, xxxx. X-11706;

xxxxxxxxxxxxxxxxxxxxxxxx-xxxxxxx xxxx (XXXX);

xxxxxxxxxx transformujícího růstového xxxxxxx xxxx (XXX-xxxx), xxxx. xxxxxxxxxxx, luspatercept;

1.2 Xxxxxxxx xxxxxxxxxxxxxxxxxx EPO xxxxxxxxx, xxxx.

XXX-290;

xxxxxx EPO;

karbamylovaný XXX;

2. Xxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxx faktoru (XXX), xxxx. xxxxxx, xxxxxxxxxx x xxxxxxxxxx (FG-4592); x xxxxxxxxxx XXX, xxxx. xxxxx x xxxxx.

3. Choriogonadotropin (CG) x xxxxxxxxxxxx hormon (XX) x jejich xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxx, xxxxxxxxxxx x xxxxxxxxxxx, x xxxx.

4. Xxxxxxxxxxxxxx x jejich xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxxxxx.

5. Xxxxxxx hormon (XX) x xxxx xxxxxxxxxx xxxxxxx xxxxxx: xxxxxxx uvolňujícího xxxxxxx xxxxxx (XXXX) x xxxx xxxxxxx, např. XXX-1295, xxxxxxxxxxx x xxxxxxxxxxxx; xxxxxxxxxxx xxxxxxxxx xxxxxxx (GHS), xxxx. xxxxxxxx x mimetik xxxxxxxx, xxxx. xxxxxxxxxxx x xxxxxxxxxxx; xxxxxxxxxxxx xxxxxxx xxxxxxxxx hormonu (XXXX), xxxx. alexamorelinu, XXXX-6, xxxxxxxxxx a xxxxxxxxxxxx (XXXX- 2).

Xxxxx xxxx jsou xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxx:

Xxxxxxxxxxxxx xxxxxxx xxxxxxx (XXXx); xxxxxxxxxxxx xxxxxxx faktor (XXX); insulinu xxxxxxx xxxxxxx xxxxxx-1 (XXX-1) x xxxx analoga; xxxxxxxxxx xxxxxxx xxxxxxx (XXX); xxxxxxx faktor xxxxxxxx x xxxxxxxx xxxxxxxx (XXXX); xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx xxxxxx (VEGF), xxxxxx xxxx xxxxxxxxx xxxx xxxxxxx faktory xxxxxxxxxxx syntézu nebo xxxxxxxxx bílkovin xxxxx, xxxxx x xxxxxx, xxxxxx xxxxxxxx, využití xxxxxxx, regenerativní kapacitu xxxx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxx.

X3. BETA2- XXXXXXXX

Xxxxxxx xxxxxxxxxx i xxxxxxxxxxxx xxxx2- xxxxxxxx, xxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxx xxxxxxxx.

Xxxxxxxx (xxx ne s xxxxxxxx xxxxx xx xx):

Xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; salmeterol; xxxxxxxxxx; vilanterol.

Výjimkou jsou:

• inhalační xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx, nepřekročit 800 xxxxxxxxxx xx každých 12 hodin;
• inhalační formoterol: xxxxxxxxx xxxxxx xxxxx 54 xxxxxxxxxx xx 24 xxxxx;
• xxxxxxxxx salmeterol: xxxxxxxxx 200 xxxxxxxxxx xx 24 hodin.

Přítomnost xxxxxxxxxxx v xxxx x xxxxxxxxxxx xxxxx xxx 1000 xx/xx x přítomnost xxxxxxxxxxx x xxxx v xxxxxxxxxxx vyšší xxx 40 xx/xx nebude xxxxxxxxxx za zamýšlené xxxxxxxxxxxx použití, ale xxxx xxxxxxxxxx za xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx farmakokinetickou studií, xx abnormální výsledek xxx xxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxx (v xxxxxxxx) xxxxx, xxx xxxx xxxxxxx xxxxxxxxx xxxxx.

X4. HORMONOVÉ A XXXXXXXXXXX XXXXXXXXXX

Xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxxx a xxxxxxxxxxx xxxxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

Xxxxxxxxxxxxxxxx;

xxxxxxxxxx;

xxxxxxxx-1,4,6-xxxxx-3-17-xxxx (androstatriendion);

androsta-3,5-dien-7-17-dion (xxxxxxxxx);

4-xxxxxxxxx-3,6,17-xxxxx (6-oxo);

exemestan;

formestan;

letrozol;

testolacton,

ale xx x omezením xxxxx xx ně.

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxxxx:

Xxxxxxxxx;

tamoxifen;

toremifen, xxx xx s xxxxxxxx xxxxx xx xx.

3. Ostatní antiestrogenní xxxxx xxxxxxxxxx:

Xxxxxxxxxx; fulvestrant x xxxxxxxx, xxx xx s xxxxxxxx xxxxx na xx.

4. Xxxxx xxxxxxxxxxxx xxxxxx(x) xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx ne

s xxxxxxxx xxxxx na xx.

5. Metaboiické modulátory:

5.1 Xxxxxxxxxx XXX-xxxxxxxxxx proteinkinázy (XXXX), xxxx. AICAR; x Xxxxxxxx Xxxxxxxxx xxxxx aktivovaného xxxxxxxxxxxxxx xxxxxxxxxxxxx (PPARδ), xxxx. XX 1516;

5.2 Xxxxxxxx x xxxxxxxx xxxxxxxx;

5.3 Xxxxxxxxx;

5.4 Xxxxxxxxxxxx.

X5. XXXXXXXXX X MASKOVACÍ XXXXX

Xxxxxxxxxxx xxxxxxxxx x xxxxxxxxx xxxxx xxxx xxxxxxxx, xxxxxx xxxx další xxxxx x podobnou xxxxxxxxx xxxxxxxxxx a xxxxxxxxx biologickými účinky.

Zahrnují:

• Desmopressin, xxxxxxxxxxxxxxx (xxxx. xxxxxxxx, xxxxxxxxxx xxxxxx xxxxxxxx, xxxxxxxx, hydroxyethylškrobu a xxxxxxxxx), xxxxxxxxxx, ale xx x omezením xxxxx xx xx.

• Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, indapamid, kanrenon, xxxxxxxx etakrynová, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx a vaptany (xxxx. xxxxxxxxx), ale xx x omezením xxxxx xx xx.

X xxxxxxxx:

• xxxxxxxxxxxx, xxxxxxxxx x xxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxxxxx (xxxx. xxxxxxxxxxx x xxxxxxxxxxxx)

• Xxxxxxxxx xxxxxx xxxxxxxxxxxx xxx xxxxx xxxxxxxxx

Xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxxxx xxxxxxx (xx. xxxxxxxxxx, xxxxxxxxxx, katin, xxxxxxx, xxxxxxxxxxxx x xxxxxxxxxxxxx) ve Vzorku Xxxxxxxxx kdykoliv xxxx

xxxxxxxx Xxx Xxxxxxx xx xxxxxxx x xxxxxxxxxx xxxx jinou xxxxxxxxx xxxxxx, bude považováno xx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxx xxxxxxxxxx Xxxxxxxxxxxxx xxxxxxx (XX) xx xxxx xxxxx xxxxx x xx, xxxxx xxx byla xxxxxxx xx xxxxxxxxxx xxxx xxxxx xxxxxxxxx xxxxx.

XXXXXXXX XXXXXX

X1. XXXXXXXXXX X XXXX A XXXXXXXX XXXXXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

1. Xxxxxx xxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxx autologní, xxxxxxxx (homologní) xxxx xxxxxxxxxxx xxxx xxxx xxxxxxxxx xxxxxxx x xxx podobných xxxxxxxx xxxxxxxxxxx původu do xxxxxxxxx xxxxxxx.

2. Umělé xxxxxxxxx xxxxxxxx, xxxxxxx xxxx xxxxxxx kyslíku.

Zahrnující:

modifikované xxxxxxxxxxxxx produkty (xxxx. xxxxxx xxxxxxxx xxxxxxxx xx hemoglobinu x xxxxxxxxxxxxxxxxxx xxxxxxxxxxx), xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxx (RSR13), xxx xx s xxxxxxxx xxxxx xx xx. Xxxxxxxxx suplementace xxxxxxxx zakázána xxxx.

3. Xxxxxxxxx xxxxx xxxxxxxxxxxxxxx xxxxxxxxxx s xxxx xxxx x xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx.

X2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

1. Xxxxxxxxx, xxxx Xxxxx x Xxxxxx, za xxxxxx xxxxxxx xxxxxxxxx x xxxxxxxx Xxxxxx xxxxxxxxxx xxx Xxxxxxxxx xxxxxxxx. Xx xxxxxxxx xxxxxx x/xxxx úpravu (např. xxxxxxxxxx) xxxx, ale xx x xxxxxxxx xxxxx na ně.

2. Xxxxxxxxxx infuze x/xxxx xxxxxxx xxxx xxx 50 ml xx 6 xxxxx xxxxx xxxxxx legitimně xxxxxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxx.

X3. XXXXXX XXXXXX

X xxxxxx xxxxxxxxxx ke xxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxxxx následující:

1. Xxxxxxxx xxxxxxxx nukleových xxxxxxx nebo jejich xxxxxxx;

2. Xxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx;

XXXXX A XXXXXX XXXXXXXX XXX SOUTĚŽI

Kromě xxxxxxxxx S0 xx X5 x M1 xx X3 xxxxxxxxx xxxx

xxxx Xxx Xxxxxxx xxxxxxxx x následující xxxxxxx:

XXXXXXXX XXXXX

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx xxxxxx všech xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx, xxxx. x- x I-, xxxx xxxxxxxx.

Xxxxxxxxxxx zahrnují:

(a) Xxxxxxxxxxxx xxxxxxxxxxx:

Xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxx /4-fenylpiracetam (karfedon)/,

furfenorex,

klobenzorex,

kokain,

kropropamid,

krotetamid,

lisdexamfetamin,

mefenorex,

mefentermin,

metamfetamin (x-),

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxxxxx, 

x-xxxxxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx.

Xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx uvedeno x xxxxx xxxxxxxx, xx Xxxxxxxxxxx xxxxxx.

(x) Xxxxxxxxxx xxxxxxxxxxx.

Xxxxxxxx (xxx ne x xxxxxxxx pouze xx xx):

Xxxxxxxxx (epinefrin)****,

benzfetamin,

dimethylamfetamin,

efedrin***,

etamivan,

etylamfetamin,

etylefrin,

famprofazon,

fenbutrazát,

fenetylamin x xxxx xxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxx),

xxxxxxxxxxxx,

xxxxx**,

xxxxxxx x xxxx xxxxxxx (např. xxxxxxxx, xxxxxxxxx x alfa-pyrolidinovalerofenon),

levmetamfetamin,

meklofenoxát,

metylefedrin***,

metylendioxymetamfetamin,

metylfenidát,

4-metylhexan-2-amin (xxxxxxxxxxxxxx),

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxx (metylsynefrin),

pemolin,

pentetrazol,

propylhexedrin,

pseudoefedrin*****,

selegilin,

sibutramin,

strychnin,

tenamfetamin (metylendioxyamfetamin),

tuaminoheptan

a xxxxx látky s xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx biologickými xxxxxx.

X xxxxxxxx:

• xxxxxxxxx

• xxxxxxxx imidazolu x xxxxxxx jejich xxxxxxxx/xxxxxx použití a xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2017*.

* Xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxx, xxxxxxx, pipradrol x xxxxxxxx: Xxxx xxxxx xxxx xxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx 2017 x nejsou považovány xx Xxxxxxxx xxxxx.

** Xxxxx: je xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx xxxx.

*** Efedrin x methylefedrin: jsou xxxxxxxx xxx xxxxxxxxxxx xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.

**** Adrenalin (xxxxxxxxx): není zakázán xxx lokálním xxxxxx, xxxx. xxxxx, oční xxxxxxxx nebo xxxx xxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxx.

***** Xxxxxxxxxxxxx: xx xxxxxxx, xxxxx xxxx koncentrace x xxxx xx xxxxx xxx 150 mikrogramů xx mililitr.

S7. NARKOTIKA

Zakázané xx xxxxxxxxxxx:

Xxxxxxxxxxx,

xxxxxxxxxxxxx,

xxxxxxxxx(xxxxxx),

xxxxxxxx x xxxx xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx.

X8. KANABINOIDY

Zakázané xx xxxxxxxxxxx:

• Xxxxxxxx (např. xxxxx, xxxxxx x xxxxxxxxx) nebo syntetický xxxxx9-xxxxxxxxxxxxxxxxxxx (THC).

• Kanabimimetika, např. "Xxxxx", XXX018, JWH073 x HU-210.

S9. XXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxx podávané xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx aplikací jsou xxxxxxxx.

XXXXX XXXXXXXX X&xxxx;XXXXXXXX XXXXXXXX

X1. ALKOHOL

Alkohol (xxxxxx) xx xxxxxxxx xxxxx Xxx Xxxxxxx v xxxxxxxxxxxxx sportech. Detekce xx bude provádět xxxxxxxx zkouškou x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx pravidla xx xxxxxxxxxxxx xxxxxxxxxxx alkoholu x xxxx 0,10 x/x.

• Xxxxxxxxxxxx sport (XXX)

• Xxxxxxxxxxx (XX)

• Xxxxxxx sporty a xxxxxxxxxxxx (FAI)

• Vodní motorismus (XXX)

X2. XXXX-XXXXXXXXX

Xxxx-xxxxxxxxx xxxx xxxxxxxx pouze x xxxxxxxxxxxxx xxxxxxxx Xxx Xxxxxxx, x xxx xx xx xxxxxxxx x Xxxx soutěž.

• Automobilový xxxxx (XXX)

• Xxxxxxxx (xxxxxxx xxxxxxxxxx) (XXXX)

• Xxxx (XXX)

• Xxxxxxxxxxx (XX)*

• Xxxxxxxx (XXX) - xxxxx na lyžích x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

• Xxxxxxxx xxxxxx (xxxxxxxxx potápění) (XXXX) x xxxxxxxxxxxx xxxxxxxxxx xxxx s ploutvemi xxxx xxx xxxxxxx, xxxxxxxxx xxxxx x xxxxxxxxx xxxx bez xxxxxxx, free xxxxxxxxx, xxxx blue, xxxxxxxxxxxx, xxxxxxxx xxxxx, xxxxxxx xxxxxxxx na xxxx x xxxxxxxxxx xxxx.

• Xxxxxxx (XXXX, XXX)*

• Xxxxx (WDF)

* Xxxxxxxx xxxx Xxxx xxxxxx

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Xxxxxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxxx,

xxxxxxx,

xxxxxxxxx,

xxxxxxxxxx,

xxxxxxxxx,

xxxxxxxxxxx,

xxxxxxxxxxxx,

xxxxxxxxxx, 

xxxxxxx,

xxxxxxxxxx,

xxxxxxxx,

xxxxxxxxxxx,

xxxxxxx,

xxxxxxx,

xxx xx x xxxxxxxx xxxxx xx xx.

Xxxxxxxxx

Xxxxxx xxxxxxx x. 80/2017 Xx. m. x. xxxxx xxxxxxxxx xxxx 4.1.2018.

Xxxxxx předpis x. 80/2017 Xx. x. s. xxx xxxxxx právním předpisem č. 36/2019 Sb. m. s. x účinností xx 26.7.2019.

Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.

1) Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve xxxxxx, xxxxxxx dne 19. xxxxx 2005 x Xxxxxx, byla xxxxxxxxx v anglickém xxxxx x x xxxxxxxxx do xxxxxxx xxxxxx xxx č. 58/2007 Sb. m. s.

Xxxx xxxxx xxxxxxxx Xxxxxx xx xxxxxxx xxxxxx xxxx xxxxxxxxx pod č. 46/2008 Sb. m. s.